EMBARGOED FOR RELEASE UNTIL
MAY 1, 2007
APS Contact
Donna Krupa
Office: (301) 634-7209
Cell: (703) 967-2751
dkrupa@the-aps.org
Newsroom Opens at 12:00 p.m.
Saturday April 28
APS Newsroom
East Registration Area
Washington Convention Center
APS Press Room: (202) 249-4174
Lap Band Gastric Bypass
Surgery Improves Insulin Resistance
Morbidly obese undergoing the
lesser known less invasive laparoscopic gastric banding surgery (LGBS) show
improvements six months after surgery
WASHINGTON – A new study examining the overall
and gender-related effects of laparoscopic gastric banding surgery (LGBS) on
insulin resistance, body composition, and metabolic risk markers six months
post-surgery has found significant improvements in insulin resistance. The
improvements occurred despite continuing obesity.
The results are from the study entitled Insulin
Resistance, Metabolic Risk Factors and Body Composition Six Months after
Laparoscopic Gastric Banding Surgery. Joan F. Carroll,
Department of Integrative Physiology and Susan F. Franks, Departments of
Family Medicine and Psychology, University of North Texas Health Science
Center; Adam B. Smith, Laparoscopy, Bariatrics, and Surgery, and David R.
Phelps, Radiology Associates of Tarrant County, Fort Worth, TX conducted the
investigation.
Dr. Carroll is presenting the team’s findings at the
120th annual meeting of the American Physiological Society (APS;
www.The-APS.org), being held as part of the Experimental Biology (EB
’07) conference. More than 12,000 scientific researchers will attend the
gathering being held April 28-May 2, 2007 at the Washington, DC Convention
Center.
Background
Overweight and obesity
have reached epidemic proportions in the United States. In fact, 65 percent
of Americans are currently considered overweight or obese. Using body mass
index (BMI) standards, overweight is defined as BMI between 25-30 kg/m2;
obesity is defined as BMI>30 kg/m2.
Excess body fat is not
simply a cosmetic problem; it constitutes a health risk as well. As the
amount of adipose tissue (body fat) increases, the concentrations of
substances produced in adipose tissue can become grossly abnormal. In
addition, fat becomes deposited in the pancreas, liver and muscle, leading
to metabolic derangements such as insulin resistance and/or diabetes.
Obesity causes hypertension and abnormal levels of fat in the blood.
Because of the low success
rate of calorie restriction (i.e., diets) in reducing morbid obesity,
surgical intervention is increasingly common. Individuals are considered
candidates for surgery if BMI>40 kg/m2, or if BMI is 35-40 kg/m2
with significant co-morbidities.
Roux-en-Y Gastric
Bypass vs. Laparoscopic Gastric Banding Surgery
Roux-en-Y Gastric Bypass (RYGB)
is the most commonly performed bariatric operation in the US, and often
considered the “gold standard” by which other surgical procedures are
judged. This procedure involves a rearrangement of the gastrointestinal (GI)
architecture so that food bypasses about 95 percent of the stomach and large
parts of the small intestine. In contrast, LGBS involves only a restriction
on the stomach, so that less food can be ingested. In this procedure, an
inflatable silicone band is placed around the top of the stomach in order to
create a small stomach pouch. The band can be filled with varying volumes of
saline so that the outlet from the small stomach pouch can vary in size.
Thus, the speed of emptying food from the stomach can vary. With LGBS, there
is no rearrangement of the gastrointestinal architecture and food that is
ingested does not bypass any of the GI tract.
Many studies have shown
that RYGB is very successful in controlling diabetes, even before
substantial weight loss has occurred. Fewer studies investigating reductions
in cardiovascular and metabolic risk factors after LGBS have been published.
This study was undertaken to determine the overall and gender-related
effects of LGBS on body composition, insulin resistance, and metabolic risk
markers six months after LGBS.
Methodology
Volunteers were recruited
from a physician practice performing LGBS surgery. Patients had previously
been screened by a physician and determined to be appropriate candidates for
surgery. The intent was to follow patients for one year post-surgery. As of
March 2007, 12 men and 17 women have been followed for six months
post-surgery.
Before surgery, the team
evaluated body composition using a variety of methods. Total visceral
adipose tissue (VAT) and VAT at the L4L5 spinal level were determined using
a multi-slice CT scanner. Body weight and height were measured and BMI was
calculated. Waist and hip circumferences were measured and the waist-to-hip
ratio was calculated. Body fat percentage was measured using bioimpedance.
Fasting blood samples were
taken to evaluate metabolic risk biomarkers, including blood lipids,
insulin, glucose, cardiac C-reactive protein (CRP), fatty acids,
homocysteine, hemoglobin A1 (HbA1c), ApoA1, and ApoB. Resting blood pressure
was also measured.
Insulin resistance was
estimated using a simple index (HOMA) that is based on fasting plasma
insulin and glucose concentrations.
Results
The researchers found the
following:
prior to surgery, there were expected gender differences in
body composition measures. Men were heavier, had greater waist
circumferences, L4L5 VAT, total VAT, and HbA1c. Women had higher a
percentage of body fat.
six months after surgery the overall group had a l5 percent
reduction in body weight (275 vs. 233 pounds), a 14 percent reduction in BMI
(43.4 vs. 37.3), a 13 percent reduction in body fat percentage (49 vs. 43
percent), a 13 percent reduction in waist circumference (53 vs. 46 inches)
and a 10 percent reduction in hip circumference (57 vs. 51 inches). Total
VAT was reduced by 20 percent (6.5 vs. 5.2 kg).
six-months after surgery the insulin resistance was reduced 60
percent, according to a HOMA score. This was due primarily to a 50 percent
reduction in fasting insulin concentrations with no change in fasting
glucose concentrations.
there were a few gender differences in surgery-related
changes. In women only, the waist-to-hip ratio tended to decrease (0.92 vs.
0.86), and the HbA1c tended to decrease (5.8 vs. 5.6 percent). In men only,
total VAT was significantly reduced (8.7 vs. 6.6 kg). Diastolic blood
pressured tended to decrease (81 vs. 75 mmHg) and CRP tended to decrease
(8.3 vs. 4.7 mg/L).
Conclusions
Many studies have shown
the benefit of RYGB surgery for improvement in insulin resistance in
morbidly obese patients. This study demonstrates that there are also
significant improvements in insulin resistance six months after LGBS. After
six months, the largest and most significant changes in the group were
variables suggestive of insulin resistance. These improvements occurred
despite the fact that patients were still clinically obese. Rapid
improvements in insulin resistance after surgery will have a positive impact
on long-term patient health and may delay or prevent progression to
diabetes.
***
.The
American Physiological Society (APS) has been an integral part of the
scientific discovery process since it was established in 1887. Physiology
is the study of how molecules, cells, tissues and organs function to create
health or disease.
# # #
NOTE TO EDITORS: The APS annual meeting is part
of the Experimental Biology 2007 (EB ’07) gathering and will be held April
28-May 2, 2007 at the Washington, DC Convention Center. To schedule an
interview with Dr. Carroll, please contact Donna Krupa in the newsroom at
202.249.4174, 301.634.7209 (direct dial), 703.967.2751 (cell) or
DKrupa@the-APS.org.
|